****** Alzheimer’s disease has stumped researchers for decades. Despite a worldwide effort to develop a cure, the progression of Alzheimer’s remains untreatable. However, new research allowing for early detection may provide the key to effective treatment. According to a press release issued by the American Osteopathic Association, researchers from Rowan University School of Osteopathic Medicine have developed a blood test that is able to detect an early stage of f Alzheimer’s disease with unparalleled accuracy. The researchers believe this development could provide the key not only to early diagnosis but also to more effective treatment. Alzheimer’s disease is a type of dementia that can impair memory, thought processing and behavior, according to the Alzheimer’s Association. More than five million Americans have Alzheimer’s--the majority of which are over 65 years old. Patients diagnosed with Alzheimer’s live an average of only eight years after their symptoms become noticeable to others.